This event is run at arm's length from the financial supporters including Pfizer, Sanofi and CSL Seqirus. All content was created by the faculty. No funder has had input into the content of the materials or presentations. This study day is part funded by corporate sponsorship from Pfizer who had no input into speaker selection, content development or event promotion. CSL has provided funding towards this independent programme and has had no input into the agenda, speaker selection, or content of the event.

Event Schedule

Wednesday, May 6, 2026
9:30 AM - 10:25 AM
Chair's Opening Remarks followed by: Panel Discussion: Equity in immunisation and vaccines hesitancy
 
 
 
10:40 AM - 11:25 AM
The gonorrhea vaccine programme, what do we need to know in primary care?
  • Background and overview UK gonorrhea program (increasing incidence, increasing AMR, economic burden, prevention strategy) 
  • Disease overview (transmission, increase in asymptomatic infections, complications, AMR) 
  • The vaccine – what you need to know (mechanism, eligibility and risk groups) 
  • How primary care can help (identification and signposting, patient conversations, reducing inequalities) 
  • Q+A
 
 
11:40 AM - 12:25 PM
Improving seasonal vaccine uptake in low-coverage populations: from evidence to community impact
  • How vaccination programmes are evolving and the implications for equity and access
  • Understanding low uptake: population demographics, behavioural drivers, and structural barriers
  • Tackling misinformation and building vaccine confidence in underserved communities
  • Community engagement strategies that work: partnerships, outreach models, and culturally competent approaches
  • Applying evidence in practice: interpreting data to inform targeted interventions
  • Practical approaches to improving uptake: call/recall systems, co-administration, and service design for hard-to-reach groups
  • Q+A
 
 
12:40 PM - 1:25 PM
From flu to RSV, navigating the respiratory vaccine landscape
  • Epidemiology and burden of respiratory infections
  • Updates on influenza vaccines, RSV prevention (infants and children, older adults) and other respiratory immunisations 
  • Navigating the vaccine landscape in practice 
  • JCVI and guidance updates
  • Q+A 
 
 
1:40 PM - 2:25 PM
Travel health in transition: trends shaping clinical practice
  • Overview of changing global travel patterns, evolving traveller demographics, and increasing demand across primary care
  • Emerging and re-emerging infectious disease risks, including mosquito-borne illnesses, outbreak-prone diseases, and climate-driven shifts
  • Vaccine developments and practical application in travel health (routine and specialist vaccines)
  • Supporting clinicians in practice: risk assessment, pre-travel advice, and recognising when to refer
  • Q&A
 
 
2:40 PM - 3:25 PM
Beyond flu and COVID-19 (pneumococcal and shingles)
  • Why this matters now (shifting burden of vaccine‑preventable diseases, missed opportunities in primary care) 
  • Shingles: what primary care needs to know (inc. disease overview, epidemiology and overview national guidance, vaccination options, framing risk to patients) 
  • Pneumococcal disease: what primary care needs to know (inc. practical care considerations, identifying eligible patients, co-admin with other vaccine, complex cases, common misconceptions) 
  • Q+A
 
 
3:40 PM - 4:25 PM
Chickenpox (Varicella) vaccine: what primary care needs to know
  • Disease overview (Varicella-zoster virus and transmission)
  • JCVI recommendations
  • Vaccination options (Varicella vaccines and schedules, Co-administration with MMR)
  • Addressing “mild disease” perceptions
  • Discussing complications and community protection
  • Q+A
     
 
 
4:25 PM - 4:35 PM
Closing remarks
 
 
 
 
4:35 PM
Conference ends
 
 
 
 

5.25 CPD hours

Speakers

Professor Sir Jonathan Van-Tam
Professor Sir Jonathan Van-Tam
Former Deputy Chief Medical Officer England, Emeritus Professor, University of Nottingham
Sander Van der Linden
Sander Van der Linden
Professor of Psychology, University of Cambridge
Lydia Langridge
Lydia Langridge
CHIS IIU Team Senior Clinician, NHS South Central and West Commissioning Support Unit
Susie Scales
Susie Scales
Clinical lead for school nursing, Derby City, Professional officer, SAPHNA
Dr Helen Wall
Dr Helen Wall
GP Partner, The Oaks Family practice, Bolton
Prof Elena Mitsi
Prof Elena Mitsi
Associate Professor of Infection and Mucosal Immunology, Oxford Vaccine Group, Department of Paediatrics, University of Oxford
Yvonne Gibney
Yvonne Gibney
Travel Health Nurse Specialist
Dr Borja Mora-Peris
Dr Borja Mora-Peris
Consultant in HIV and sexual health, Imperial College Healthcare
Dr Tehseen Khan
Dr Tehseen Khan
GP Spring Hill Practice, Clinical Director Springfield Park Primary Care Network, Clinical Lead City and Hackney Neighbourhoods, Clinical Advisor NHS England- London
Dr Roger Henderson
Dr Roger Henderson
GP and Health Broadcaster
Stacy Evans
Stacy Evans
Practice Nurse and Immunisation trainer, Cheshire and Merseyside